edarbyclor 40 mg/12.5 mg comprimés pelliculés
takeda pharma ag - azilsartanum medoxomilum, chlortalidonum - comprimés pelliculés - azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum, chlortalidonum 12.5 mg, mannitolum, cellulosum microcristallinum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, crospovidonum, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), pro compresso obducto corresp. natrium 0.4 mg. - l'hypertension - synthetika
edarbyclor 40 mg/25 mg comprimés pelliculés
takeda pharma ag - azilsartanum medoxomilum, chlortalidonum - comprimés pelliculés - azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum, chlortalidonum 25 mg, mannitolum, cellulosum microcristallinum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, crospovidonum, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), pro compresso obducto corresp. natrium 0.4 mg. - l'hypertension - synthetika
edarbyclor comprimé
bausch health, canada inc. - azilsartan médoxomil (azilsartan médoxomil potassium); chlorthalidone - comprimé - 40mg; 12.5mg - azilsartan médoxomil (azilsartan médoxomil potassium) 40mg; chlorthalidone 12.5mg - angiotensin ii receptor antagonists
edarbyclor comprimé
bausch health, canada inc. - azilsartan médoxomil (azilsartan médoxomil potassium); chlorthalidone - comprimé - 40mg; 25mg - azilsartan médoxomil (azilsartan médoxomil potassium) 40mg; chlorthalidone 25mg - angiotensin ii receptor antagonists
edarbyclor comprimé
bausch health, canada inc. - azilsartan médoxomil (azilsartan médoxomil potassium); chlorthalidone - comprimé - 80mg; 12.5mg - azilsartan médoxomil (azilsartan médoxomil potassium) 80mg; chlorthalidone 12.5mg - angiotensin ii receptor antagonists
flucelvax tetra
seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - grippe humaine - la grippe, inactivé, virus fragmenté ou antigène de surface - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra doit être utilisé conformément aux recommandations officielles.
optaflu
seqirus gmbh - virus de la grippe antigènes de surface (hémagglutinine et neuraminidase), inactivé, des souches suivantes:a/california/7/2009 (h1n1)pdm09 - souche analogue à a/brisbane/10/2010, type sauvage), a/suisse/9715293/2013 (h3n2) - souche analogue à a/sud australie/55/2014, type sauvage)b/phuket/3073/2013–souche analogue à b/utah/9/2014, type sauvage) - influenza, human; immunization - vaccins - prophylaxie de la grippe chez les adultes, en particulier chez ceux qui présentent un risque accru de complications associées. optaflu doit être utilisé selon les recommandations officielles.
flucelvax quad suspension
seqirus uk limited - hémagglutinine-souche a (h1n1); hémagglutinine-souche a (h3n2); hémagglutinine-souche b (victoria); hémagglutinine-souche b (yamagata) - suspension - 15mcg; 15mcg; 15mcg; 15mcg - hémagglutinine-souche a (h1n1) 15mcg; hémagglutinine-souche a (h3n2) 15mcg; hémagglutinine-souche b (victoria) 15mcg; hémagglutinine-souche b (yamagata) 15mcg - vaccines
flucelvax quad suspension
seqirus uk limited - hémagglutinine-souche b (victoria); hémagglutinine-souche b (yamagata); hémagglutinine-souche a (h3n2); hémagglutinine-souche a (h1n1) - suspension - 15mcg; 15mcg; 15mcg; 15mcg - hémagglutinine-souche b (victoria) 15mcg; hémagglutinine-souche b (yamagata) 15mcg; hémagglutinine-souche a (h3n2) 15mcg; hémagglutinine-souche a (h1n1) 15mcg - vaccines
zovirax pommade
bausch health, canada inc. - acyclovir - pommade - 5% - acyclovir 5% - antivirals